A Phase 1B Dose-escalation and Phase 2a Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 13 Sep 2017
At a glance
- Drugs Carotuximab (Primary) ; Pazopanib
- Indications Haemangiosarcoma; Sarcoma; Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors TRACON Pharmaceuticals
- 07 Sep 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.
- 05 Jun 2017 Results of presented at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting, according to a TRACON Pharmaceuticals media release.
- 28 Nov 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History